{"disease":{"id":"microcystic-lymphatic-malformation","name":"microcystic lymphatic malformation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04128722","title":"TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT05050149","title":"Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Palvella Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06160739","title":"Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations","phase":"","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Sohag University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}